ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Melanin-Like Nanomedicine Functions as a Novel RPE Ferroptosis Inhibitor to Ameliorate Retinal Degeneration and Visual Impairment in Dry Age-Related Macular Degeneration

Huang, Keke; Deng, Haoyue; Wang, Shuang; Zhang, Fuxiao; Huang, Ge; Wang, Lu; Liu, Jianyu; Zhao, Xuli*; Ren, Hui*; Yang, Guang*; Lin, Zhiqing*西南交通大学
Advanced Healthcare Materials2024-12DOI: 10.1002/adhm.202401613
2阅读
引用收藏
分享

摘要

Ferrous ion accumulation and lethal oxidative stress mediate irreversible retinal pigment epithelial (RPE) cell ferroptosis and subsequent photoreceptor degeneration, a potential key pathogenic factor in the onset of dry age-related macular degeneration (dAMD), causing irreversible vision loss in the global elderly population. However, currently, no effective interventional treatment strategy exists in clinical practice. Herein, lesion site-targeted melanin-like nanoparticles, named ConA-MelNPs, are designed as a novel ferroptosis inhibitor for retinal degenerative diseases. ConA-MelNPs possessed chelating iron ion characteristics, alleviating severe mitochondrial damage caused by oxidative stress and protecting RPE cells from ferroptosis induced by sodium iodate (NaIO3). In a preclinical dAMD mouse model, a single intravitreal injection of ConA-MelNPs yielded significant responses in electroretinograms and visually-driven optomotor responses in visually impaired mice, resisting the challenge posed by secondary NaIO3-induced injuries, with the long-term sustainability of its therapeutic effect. Mechanistically, ConA-MelNPs achieve a therapeutic effect by interrupting the detrimental cascade involving "RPE cell ferroptosis, lethal oxidative stress, and microglial proinflammatory activation," affording the restoration of retinal homeostasis. The synthesized ConA-MelNPs demonstrated good biosafety, with no detected ophthalmic or systemic side effects. Collectively, ConA-MelNPs are proposed as a promising therapeutic option for atrophic retinal diseases such as dAMD. The schematic illustration depicts the creation of ConA-MelNPs, which provides a multifaceted therapeutic impact, effectively targeting the intertwined issues of RPE cell ferroptosis, fatal oxidative stress, and microglial inflammatory responses. This integrated approach aims to stabilize the ocular microenvironment, reestablishing retinal equilibrium and, in the case of dAMD mouse models, potentially reviving visual capabilities. image

学科与关键词

关键词
(Dry age-related macular degenerationferroptosismelanin-like nanomedicineoxidative stress)retinal pigmented epithelial
相关
加载中…
  • PEDF protects retinal pigment epithelium from ferroptosis and ameliorates dry AMD-like pathology in a murine model
    Xiang, Wei; Li, Longhui; Zhao, Qin; Zeng, Yongcheng; Shi, Jinhui; Chen, Zitong; Gao, Guoquan*; Lai, Kunbei*GeroScience, 2024, 46(2): 2697-2714.
  • Ferroptosis drives photoreceptor degeneration in mice with defects in all-trans-retinal clearance
    Chen, Chao; Chen, Jingmeng; Wang, Yan; Liu, Zuguo; Wu, Yalin*Journal of Biological Chemistry, 2021, 296: 100187.被引 47
  • FA/Mel@ZnO nanoparticles as drug self-delivery systems for RPE protection against oxidative stress
    Yi, Caixia; Yu, Zhihai; Sun, Xin; Zheng, Xi; Yang, Shuangya; Liu, Hengchuan; Song, Yi*; Huang, Xiao*Advances in Nano Research, 2022, 13(1): 87-96.被引 3
查看全部 →

发表信息

论文状态
公开发表
期刊
Advanced Healthcare Materials
发表日期
2024-12
卷期
第 13 卷, 第 30 期
DOI
10.1002/adhm.202401613
语言
ENGLISH
成果收录
SCIE
资助标注
Chengdu Medical Scientific Research Project [2023028, 2022282]; Chengdu Science and Technology Bureau's technology innovation research and development project [2022-YF05-01861-SN, 2024-YF05-00901-SN]; Third People's Hospital of Chengdu Scientific Research Project [2023PI23]; Youth Project of Sichuan Medical and Health Promotion Association [KY2023QN0014]

作者

  • H

    Huang, Keke (第一作者)

    southwest jiaotong univ

  • D

    Deng, Haoyue

    third mil med univ

查看全部 11 位作者收起作者
  • W

    Wang, Shuang

    southwest jiaotong univ

  • Z

    Zhang, Fuxiao

    chengdu med coll · peoples hosp chengdu 2

  • H

    Huang, Ge

    chengdu med coll · peoples hosp chengdu 2

  • W

    Wang, Lu

    chengdu med coll · peoples hosp chengdu 2

  • L

    Liu, Jianyu

    southwest jiaotong univ

  • Z

    Zhao, Xuli (通讯)

    chengdu med coll · peoples hosp chengdu 2

  • R

    Ren, Hui (通讯)

    chengdu med coll · peoples hosp chengdu 2

  • Y

    Yang, Guang (通讯)

    chengdu med coll · peoples hosp chengdu 2

  • L

    Lin, Zhiqing (通讯)

    chengdu med coll · peoples hosp chengdu 2

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417